Email this article The optimization of diagnostic of cervix cancer
- Authors: Alyautdina O.S.1, Sinitsina O.V2
-
Affiliations:
- The medical center MedSwiss
- The Moscow municipal oncological hospital № 62
- Issue: Vol 21, No 6 (2015)
- Pages: 25-27
- Section: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38283
- DOI: https://doi.org/10.17816/rmj38283
- ID: 38283
Cite item
Full Text
Abstract
The cervix cancer is one of the most prevalent oncological diseases. so far as viruses of human papilloma play determining role in development of this pathology the most important significance in their diagnostic acquire modern techniques of laboratory analyses. In the process of determination of algorithm of monitoring of female patients infected by virus of human papilloma such innovative diagnostic techniques were implemented as fluid cytology and identification of oncoprotein p16 ink4a. It is demonstrated that in female patients infected with virus of human papilloma the clinical picture very often had no equivalence to intensity of pathological process under cytological diagnostic. Thereupon, the algorithm was developed related to monitoring of female patients under different combined alternatives of clinical and cytological manifestation of cervix dysplasia.
Full Text
##article.viewOnOriginalSite##About the authors
Ol’ga S. Alyautdina
The medical center MedSwiss
Email: olasa@list.ru
MD, PhD, DSc, prof. Moscow, Russia
O. V Sinitsina
The Moscow municipal oncological hospital № 62Moscow, Russia
References
- Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA. Cancer J. Clin. 2011; 61: 69-90.
- Jacobs M.V., Snijders P.F., Voohorst F.L., Dillner J., Forslund O., Johansson B. et al. Reliable high risk HPV DNA testing by polymerase chain reaction: an inter-method and intra-method comparison. J. Clin. Pathol. 1999; 52: 498-503.
- Follen M., Richard-Kortum R. Emerging technologies and cervical cancer. J. Natl.Cancer Inst. 2000; 92: 363-5.
- Walboomers J.M., Jacobs M.V., Manos M.M. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999; 189: 12-9.
- Moscicki A.B., Shiboski S., Broering J. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J. Pediatr. 1998; 132: 277-84.
- Киселев В.И., Муйжнек Е.Л. Молекулярные механизмы развития дисплазии шейки матки: Новые знания - новые возможности. М.: ИльмиксГрупп; 2012.
- Карахалис Л.Ю., Зуева Т.П., Петренко С.И. Оптимизация терапии дисплазий шейки матки, ассоциированных с ВПЧ-инфекцией. Проблемы репродукции. 2012; 5: 1-4.
- Roelens J., Reuschenbach M., von Knebel Doeberitz M., Wentzensen N., Bergeron C., Arbyn M. p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis. Cancer Cytopathol. 2012; 120; 294-307.
- Lesnikova I., Lidang M., Hamilton-Dutoit S., Koch J. p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens. Diagn. Pathol. 2009; 4: 22.
